These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36715084)

  • 1. Lipin1 plays complementary roles in myofibre stability and regeneration in dystrophic muscles.
    Jama A; Alshudukhi AA; Burke S; Dong L; Kamau JK; Voss AA; Ren H
    J Physiol; 2023 Mar; 601(5):961-978. PubMed ID: 36715084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring lipin1 as a promising therapeutic target for the treatment of Duchenne muscular dystrophy.
    Jama A; Alshudukhi AA; Burke S; Dong L; Kamau JK; Morris B; Alkhomsi IA; Finck BN; Voss AA; Ren H
    J Transl Med; 2024 Jul; 22(1):664. PubMed ID: 39014470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.
    Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA
    Neurogenetics; 2006 May; 7(2):81-91. PubMed ID: 16525850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing muscle contractility through low-frequency stimulation alters tibial bone geometry and reduces bone strength in
    Chan AS; Hardee JP; Blank M; Cho EH; McGregor NE; Sims NA; Lynch GS
    J Appl Physiol (1985); 2023 Jul; 135(1):77-87. PubMed ID: 37262103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
    Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
    Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic HDAC4 regulates the membrane repair mechanism in Duchenne muscular dystrophy.
    Renzini A; Marroncelli N; Cavioli G; Di Francescantonio S; Forcina L; Lambridis A; Di Giorgio E; Valente S; Mai A; Brancolini C; Giampietri C; Magenta A; De Santa F; Adamo S; Coletti D; Moresi V
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1339-1359. PubMed ID: 35170869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45-47.
    Heier CR; McCormack NM; Tully CB; Novak JS; Newell-Stamper BL; Russell AJ; Fiorillo AA
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):940-954. PubMed ID: 36628607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
    Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
    EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle.
    Kennedy TL; Swiderski K; Murphy KT; Gehrig SM; Curl CL; Chandramouli C; Febbraio MA; Delbridge LM; Koopman R; Lynch GS
    Am J Pathol; 2016 Dec; 186(12):3246-3260. PubMed ID: 27750047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necroptosis mediates myofibre death in dystrophin-deficient mice.
    Morgan JE; Prola A; Mariot V; Pini V; Meng J; Hourde C; Dumonceaux J; Conti F; Relaix F; Authier FJ; Tiret L; Muntoni F; Bencze M
    Nat Commun; 2018 Sep; 9(1):3655. PubMed ID: 30194302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy.
    Alves FM; Kysenius K; Caldow MK; Hardee JP; Chung JD; Trieu J; Hare DJ; Crouch PJ; Ayton S; Bush AI; Lynch GS; Koopman R
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1541-1553. PubMed ID: 35249268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways.
    Sadler KJ; Gatta PAD; Naim T; Wallace MA; Lee A; Zaw T; Lindsay A; Chung RS; Bello L; Pegoraro E; Lamon S; Lynch GS; Russell AP
    Exp Physiol; 2021 Jul; 106(7):1597-1611. PubMed ID: 33963617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmin prevents muscle wasting, exaggerated weakness and fragility, and fatigue in dystrophic mdx mouse.
    Ferry A; Messéant J; Parlakian A; Lemaitre M; Roy P; Delacroix C; Lilienbaum A; Hovhannisyan Y; Furling D; Klein A; Li Z; Agbulut O
    J Physiol; 2020 Sep; 598(17):3667-3689. PubMed ID: 32515007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of the sarcolemma-enriched fraction from dystrophic mdx-4cv skeletal muscle.
    Murphy S; Zweyer M; Henry M; Meleady P; Mundegar RR; Swandulla D; Ohlendieck K
    J Proteomics; 2019 Jan; 191():212-227. PubMed ID: 29408692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pannexin 1 dysregulation in Duchenne muscular dystrophy and its exacerbation of dystrophic features in mdx mice.
    Freeman E; Langlois S; Leyba MF; Ammar T; Léger Z; McMillan HJ; Renaud JM; Jasmin BJ; Cowan KN
    Skelet Muscle; 2024 Apr; 14(1):8. PubMed ID: 38671506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle specific kinase protects dystrophic mdx mouse muscles from eccentric contraction-induced loss of force-producing capacity.
    Trajanovska S; Ban J; Huang J; Gregorevic P; Morsch M; Allen DG; Phillips WD
    J Physiol; 2019 Sep; 597(18):4831-4850. PubMed ID: 31340406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
    Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
    Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin-desmin double knockout (DKO) mouse.
    Moutachi D; Hyzewicz J; Roy P; Lemaitre M; Bachasson D; Amthor H; Ritvos O; Li Z; Furling D; Agbulut O; Ferry A
    J Physiol; 2024 Aug; 602(15):3641-3660. PubMed ID: 38980963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.